openPR Logo
Press release

Asia-Pacific Precision Medicine Market to Grow at a CAGR of 16.63% with revenue of USD 20.90 Billion | Key Vendors – Pfizer, Novartis, Teva

01-08-2019 04:40 AM CET | Health & Medicine

Press release from: Business Industry Reports

Precision Medicine Market

Precision Medicine Market

A fresh report has been added to the wide database of Business Industry Reports. The research study is titled “Precision Medicine Market” by Manufacturers, Countries, Type and Application, Forecast to 2023 which provides important data about the production, consumption, revenue and company profiles for key industry participants.

Asia-Pacific Precision Medicine Market Synopsis:

According to Market Analyst, The Asia-Pacific precision medicine market is projected to grow at a compound annual growth rate (CAGR) of 16.63%, leading to a revenue of USD 20.90 Bn by 2023.

Get Free Sample Study Papers of “Asia-Pacific Precision Medicine Market” @ https://www.businessindustryreports.com/sample-request/122778 .

Asia-Pacific is the fastest growing precision medicine market in the world. Major countries like China, India and Japan are adopting healthcare technologies at a rapid pace, resulting in improvements in the treatments and solutions for uncommon diseases. This is why the demand for precision medicine is also increasing. The adoption of gene therapy - which is essential for the development of precision medicine - is responsible for the growth of the market. Further, the increasing rate of chronic diseases and enhancements in big data analytics will also drive the precision medicine market during the forecasted period of 2018-2023.

Asia-Pacific Precision Medicine Market can be segmented on the Basis of ecosystem players, therapeutics and technology. On the Basis of ecosystem players, Asia-Pacific Precision Medicine Market can be sub segmented into pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies. Diagnostic tool companies are expected to exhibit the highest growth rate in the region due to increased investments in research and technology, and clinical trials in the region.

Based on therapeutics, Market Can be segmented into cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases. The cancer therapeutics segment is expected to register the highest growth rate during the forecasted period 2018-2023 due to higher incidence of cancer. Based on technology, Market can be segmented into big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics.

Complete report on Asia-Pacific Precision Medicine Market spread across 90 Pages and No. of Table of contents. Buy Research at https://www.businessindustryreports.com/buy-now/122778/single .

Based on countries, China is dominating the precision medicine market due to its ageing population and rise in the rate of chronic diseases. India is experiencing the fastest growth in the Asia- Pacific region. Rising investments in research and development have also triggered the growth of the precision medicine market.

The Market is segmented and projected on the basis of major key player’s:

1 Pfizer

2 Novartis

3 Teva pharmaceuticals Industries etc.

Market segment by Regions/Countries, this report covers:

1 China

2 India

3 Japan

Request a Discount on standard prices of this premium report at https://www.businessindustryreports.com/check-discount/122778 .

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

Key Questions Answered in this Report:

1 What will the market size be in 2023?

2 What is driving this market??

3 What are the challenges to market growth?

4 Who are the key players in Precision Medicine Market?

5 What are the market opportunities and threats faced by the key players?

TABLE OF CONTENTS

1 Executive summary

2 Asia-Pacific precision medicine market - overview

3 Asia-Pacific precision medicine market- by countries

4 Competitive landscape

5 Conclusion

6 Appendix

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific Precision Medicine Market to Grow at a CAGR of 16.63% with revenue of USD 20.90 Billion | Key Vendors – Pfizer, Novartis, Teva here

News-ID: 1476955 • Views: 230

More Releases from Business Industry Reports

2020-2025 Neoantigen Targeted Therapies Market to witness astonishing growth wit …
Global Neoantigen Targeted Therapies Market Synopsis: The report covers a forecast and an analysis of the Neoantigen Targeted Therapies Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Neoantigen Targeted Therapies Market along with the impact they have
Outstanding Scope of Nasojejunal Tube Market is Estimated to Grow Incredible CAG …
Overview of Global Nasojejunal Tube Market: This report provides in-depth study of “Global Nasojejunal Tube Market 2020” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Nasojejunal Tube Market report also provides an in-depth survey of key players in the market organization. The 'Global Nasojejunal Tube Industry, Market Research Report' is a professional and in-depth study on the current state of the global Nasojejunal Tube Market with a
Huge Investment in mTOR Inhibitors Market Expected to Witness the Highest Growth …
Global mTOR Inhibitors Market Synopsis: The exclusive research report on the Global mTOR Inhibitors Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global mTOR Inhibitors Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. According to the market research study, Mammalian Target Of Rapamycin (mTOR) is
SWOT Analysis of mRNA Treatment Market Excessive Growth Opportunities Estimated …
The exclusive research report on the Global mRNA Treatment Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global mRNA Treatment Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. Overview of Global mRNA Treatment Market: This report studies the Global mRNA Treatment Market over the forecast

All 5 Releases


More Releases for Precision

Precision Medicine Market
Precision medicine is an approach of treatment that has been derived on the basis of individual variability in environment, genes and lifestyle of each person. This novel approach assists medical practitioners and researchers to understand various treatment needs in order to prevent specific diseases. It allows for highly precise targeting of medication for treatment of various diseases, which is expected to lead to high adoption by medical practitioners and researchers.
High Precision Linear Positioners
A large variety of high precision linear positioners, XY stages and vertical linear stages is offered by PI miCos. These highly accurate systems are available with many different drive options from stepper motors to rotary servo motors and electromagnetic linear motors. Miniature stages with piezo motors are also offered. Applications for these linear motion systems include semiconductor test equipment, photonics alignment, lab-automation, bio-nanotechnology, beam line instrumentation, aerospace technology,
High Precision in Six Axes
The H-811 miniature Hexapod from PI (Physik Instrumente) has very compact dimensions with a diameter of only 130 mm and a height of 115 mm. In addition to the vacuum version, it is now also available in an air version. The H-811 offers travel ranges of up to 35 mm in the XY level and up to 13 mm in the Z direction. It is especially the large tilting angles
Precision without Position Sensor
Phase shifters are used in laser measurement to align optical path lengths. These move optics in the range of a wavelength, which corresponds to an adjustment range of less than one micrometer. It is crucial for the alignment to take place quickly and in a stable manner. For the new S-303.BL phase shifter, PI (Physik Instrumente) replaces classic piezo ceramic PZT actuators (made of lead titanate - lead zirconate) with pico
Perfectly Aligned Precision
With the new N-664 linear positioning stage, PI (Physik Instrumente) has succeeded in developing a further groundbreaking piezo positioning system of the reference class. A NEXACT® piezo linear drive replaces the usual stepper or DC servo motor in the N-664, thus making a position resolution of far less than a nanometer possible. Aligned to it is the new PIOne optical linear encoder with a resolution of 0.5 nm, which allows for
Low-Profile Vacuum Precision Stage
Confined spaces in vacuum chambers require drives and positioning solutions which are particularly compact. With a height of only 21 mm the M-683.2V4 translation stage from Physik Instrumente (PI) is one of the flattest micro-translation stages on the market, and is now also available for use in vacuum environments to 10-6 mbar. An encoder resolution of 0.1 µm over 50 mm travel makes it ideal for tasks requiring a high